Statement Of Comprehensive Income [Abstract]

Innate Pharma - Filing #882171

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Statement of comprehensive income [abstract]
Profit (loss)	52 809 EUR	—	52 809 EUR	—	63 984 EUR	63 984 EUR	—
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	—	584,000 EUR	584,000 EUR	—	200,000 EUR	—	200,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	483,000 EUR	483,000 EUR	805,000 EUR	222,000 EUR	—	1 027 EUR
Financial assets measured at fair value through other comprehensive income [abstract]
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income	—	—	— EUR	—	— EUR	—	—
Other comprehensive income	—	—	101,000 EUR	—	22,000 EUR	—	—
Comprehensive income	52 809 EUR	101,000 EUR	52 708 EUR	805,000 EUR	63 962 EUR	63 984 EUR	827,000 EUR